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Longitudinal in vivo MRI in a 
Huntington’s disease mouse model: 
Global atrophy in the absence 
of white matter microstructural 
damage
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Mark Lythgoe7, Andrew Stewart4, Anne E. Rosser2,3,8 & Derek K. Jones1,3
Huntington’s disease (HD) is a genetically-determined neurodegenerative disease. Characterising 
neuropathology in mouse models of HD is commonly restricted to cross-sectional ex vivo analyses, 
beset by tissue fixation issues. In vivo longitudinal magnetic resonance imaging (MRI) allows for 
disease progression to be probed non-invasively. In the HdhQ150 mouse model of HD, in vivo 
MRI was employed at two time points, before and after the onset of motor signs, to assess brain 
macrostructure and white matter microstructure. Ex vivo MRI, immunohistochemistry, transmission 
electron microscopy and behavioural testing were also conducted. Global brain atrophy was found in 
HdhQ150 mice at both time points, with no neuropathological progression across time and a selective 
sparing of the cerebellum. In contrast, no white matter abnormalities were detected from the MRI 
images or electron microscopy images alike. The relationship between motor function and MR-based 
structural measurements was different for the HdhQ150 and wild-type mice, although there was no 
relationship between motor deficits and histopathology. Widespread neuropathology prior to symptom 
onset is consistent with patient studies, whereas the absence of white matter abnormalities conflicts 
with patient data. The myriad reasons for this inconsistency require further attention to improve the 
translatability from mouse models of disease.
Huntington’s disease (HD) is an autosomal dominant neurodegenerative disease caused by a polyglutamine 
(CAG) repeat expansion on the huntingtin (HTT) gene1. The discovery of the mutant HTT gene led to the devel-
opment of genetic animal models which have a similar genetic defect to that seen in the human disease, allowing 
for the study of early pathological, cellular and molecular alterations caused by the mutation. Animal models 
provide a direct measure of neuropathology not possible in patients in vivo, and in comparison to patient cohorts, 
animal models can be experimentally controlled in terms of disease stage, number of CAG repeats and genetic 
background, reducing the inter-subject variance.
The longitudinal characterisation of HD mouse lines is crucial to understanding the timing, nature and sever-
ity of phenotype progression2 and ultimately to be able to translate this to the human disease. A major benefit of 
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animal models is that the whole disease course can be studied; in patients it is difficult to study structural brain 
changes in vivo in more advanced disease stages due to the incompatibility of chorea with magnetic resonance 
imaging (MRI). The majority of MRI studies using mouse models of HD have been cross-sectional. However, 
the primary value of pre-clinical (animal) MRI lies in the capability for within-subject longitudinal designs with 
increased power and experimental control to study the disease time course and evaluate therapeutic outcomes at 
different disease stages. Longitudinal MRI enables a region- and temporally-specific readout of neuropathology, 
which can inform on the design of future animal studies, allowing for the most appropriate mouse line to be 
selected.
Although the hallmark of HD is a selective loss of medium spiny neurons in the striatum, brain imaging stud-
ies have revealed white matter abnormalities at all disease stages in patients with HD3–6. The use of animal models 
allows the cellular basis of these abnormalities to be explored, and recent work in the HdhQ140 model revealed 
increased axonal swelling at 12 months but not 6 months of age in homozygote HdhQ140/Q140 mice, with no axonal 
pathology in heterozygote mice7. In the transgenic YFP(J16)-R6/2 model, marked degeneration of callosal axons 
was found prior to the onset of motor signs8. In contrast, previous work in a mouse model with a different YFP 
expression pattern (YFP(H)-R6/2) found no axonal disruption7, suggesting that axonal pathology is spatially and 
temporally selective and dependent on the specific genetic model of HD.
Diffusion MRI is a powerful method for non-invasive characterization of tissue microstructure, and is a val-
uable addition to longitudinal designs. However, whereas diffusion MRI is routinely used in human studies, it 
is technically challenging in the mouse brain, which is approximately 1000 times smaller. One issue is multiple 
white matter fibre orientations within a single imaging voxel, which cannot be resolved using the conventional 
diffusion tensor model9. We have shown that crossing fibres within an imaging voxel are present in the mouse 
brain (see Supplementary Figure S1), thus, using more sophisticated approaches which are capable of resolving 
crossing fibres will improve the sensitivity of diffusion tractography in the mouse brain.
Previous studies have used MRI to characterise neuropathological changes in transgenic mouse models of 
HD10,11 whereas in this work, we utilize a knock-in model where the genetic basis of HD is more precisely reca-
pitulated. The HdhQ150 mouse model12 was created by directly replacing the normal mouse endogenous CAG 
repeat length with an expanded 150 CAG sequence in the mouse Htt gene without affecting the rest of the endog-
enous sequence of the gene. The gene is not over-expressed and the use of the endogenous Hdh promoter means 
that a similar expression profile to that seen in the human condition is produced. The behavioural deficits of 
HdhQ150/Q150 mice have previously been well characterised longitudinally2,13 with cognitive deficits evident prior 
to motor abnormalities just as in the human disease. Ex vivo histological analysis has shown that HdhQ150/Q150 
mice display many of the characteristics of the human disease including Htt aggregation that is most marked in 
the striatum but also evident to a lesser degree in the cortex, thalamus and hippocampus, along with neuronal 
intra-nuclear inclusions12,14. These pathological changes are evident from around 5 months of age followed by 
striatal cell loss at 8 months of age14, prior to the onset of motor signs, in line with the human literature from the 
pre-symptomatic disease stage.
Despite firm evidence for grey matter pathology, it remains unclear whether white matter degeneration occurs 
in the HdhQ150 mouse model of HD. To address this question, we used in vivo MRI as a tool to investigate both 
macrostructure and microstructure pathology at both an early and late time point in the disease course.
Results
Reduced body weight in HdhQ150/Q150 mice. A genotype × time interaction was found for body weight 
(Greenhouse-Geisser corrected F12.04,145.89 = 27.30, p < 0.001, ε = 0.179, Fig. 1). HdhQ150/Q150 mice had reduced 
body weight compared to Hdh+/+ mice from 3 months of age (all p < 0.05). Modest non-significant correlations 
(r > 0.3, p > 0.05) with weight were found for the Open Field measures and for locomotion over 24 hours.
Survival and recovery from anaesthesia. There was no difference in survival between Hdh+/+ and 
HdhQ150/Q150 from 0–7 months (χ (1, n = 50) = 1.02, p > 0.05) and from 7–19 months (χ (1, n = 44) = 1.0, 
p > 0.05). Genotype did not affect recovery from anaesthesia during the MRI session at 7 months old 
(χ (1, n = 49) = 0.27, p > 0.05), however at 19-months, HdhQ150/Q150 mice were less likely to survive the scan 
(χ (1, n = 38) = 4.02, p < 0.05). Late stage behavioural tests and histological analyses are therefore based on 
correspondingly reduced and unequal group sizes.
Motor deficits are evident at 19 months old. Descriptive statistics are shown in Fig. 1.
Circadian-related activity. Habituation activity was measured over the first 2 hours; circadian-related activity 
was assessed over 24 hours. There was no effect of genotype on activity levels (F1,26 = 0.003, p > 0.05). With 
weight as a covariate, HdhQ150/Q150 mice were more active than Hdh+/+ mice during both the light and dark phase 
(F1,26 = 5.26 and 4.49 respectively, p < 0.05).
Rotarod. Averaged over 2 trials, HdhQ150/Q150 mice had a significantly shorter latency to fall from the rod, 
t27 = 3.08, p < 0.01.
Open Field Test. Total distance moved, time spent moving, velocity, and rearing frequency (standing on rear 
limbs) were significantly reduced in HdhQ150/Q150 mice (t20 = 2.39, 2.42, 2.31 and 2.75 respectively, p < 0.05). With 
body weight as a covariate, the group differences were not significant, all p > 0.05. Analysis of the univariate main 
effects revealed that the difference was driven by HdhQ150/Q150 mice engaging in rearing behaviour less frequently 
than Hdh+/+ mice (F1,22 = 10.08, p < 0.05).
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Figure 1. Behavioural Assessment at 19 months old. (A) Body weight. (B) Survival rates excluding cases 
related to anaesthesia. (C) Total number of beam breaks/hour over 24-hours. (D) Average number of beam 
breaks in the first 2 hours, and E: during the light and dark phase. (F) Latency to fall on Rotarod. (G–J) Open 
Field Test on consecutive days. (F) Movement maps made over 20-minutes by a single HdhQ150/Q150 mouse and 
single Hdh+/+ mouse. Error bars = ± standard error of the mean. *p < 0.05, **p < 0.01, ***p < 0.001.
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Global atrophy in HdhQ150/Q150 mice. Longitudinal in vivo MRI was conducted to measure volume loss 
and change in the HdhQ150 mouse brain. Atlas-based segmentation was used to delineate regions of interest 
(ROIs). The total brain volume (TBV) of HdhQ150/Q150 mice was significantly reduced compared to Hdh+/+ mice 
at both 7 months (− 5.66%) and 19 months of age (− 11.68%). After normalising the regional volumes for TBV, 
there were no volumetric differences between hemispheres (all p > 0.05), so the volumes of the left and right ROIs 
were summed.
The absolute volume of the caudate-putamen, thalamus, hippocampus, globus pallidum and cortex was sig-
nificantly reduced in HdhQ150/Q150 mice at both ages (all p < 0.05, see Fig. 2 and Table 1). However, there was no 
difference between mice in regional volumes normalised by TBV to account for global atrophy (p > 0.05, Table 1), 
with the exception of the cerebellum, which was selectively spared at both ages in HdhQ150/Q150 mice. This suggests 
that volume loss in the HdhQ150 mouse brain is global rather than region-specific and neuropathology occurs 
prior to the onset of motor signs.
In contrast to cortical volume loss, there was no difference in absolute or normalised cortical thickness in 
HdhQ150/Q150 mice at 7 months old (F1,42 = 1.37, p > 0.05, Fig. 3). At 19 months old, the motor cortices in the 
HdhQ150/Q150 mice were 8.7% thinner (F1,26 = 12.49, p < 0.01), whereas there was no effect of genotype on cortical 
thickness normalised by TBV (F1,26 = 0.47, p > 0.05).
Global volume loss is not progressive beyond 7 months in Hdh Q150/Q150 mice. Despite the smaller 
sample size at 19-months old (HdhQ150/Q150 n = 10, Hdh+/+ n = 17), a repeated-measures ANOVA examined the 
effect of time on volume. TBV did not change with time (F1,25 = 0.43, p > 0.05) although there was a trend towards 
a time × genotype interaction (F1,25 = 7.75, p = 0.01 uncorrected, p > 0.05). Ventricular volume increased with 
Figure 2. Longitudinal in vivo MRI atlas-based segmentation of T2-weighted images. Top panel shows 
segmented ROI masks in the axial and coronal plane ([1] caudate-putamen; [2] cortex; [3] cerebellum;  
[4] thalamus; [5] globus pallidum; [6] hippocampus; [7] ventricles) overlaid on a T2-weighted image from a  
20-month old wild-type mouse. Absolute volumes presented as means ± SEM.
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time (F1,25 = 7.70, p < 0.05). There was no effect of time on absolute volume of the caudate-putamen (F1,25 = 2.65, 
p > 0.05), thalamus (F1,24 = 0.04, p > 0.05), hippocampus (F1,25 = 2.26, p > 0.05), globus pallidum (F1,22 = 0.08, 
p > 0.05), and cortex (F1,25 = 2.38, p > 0.05). For all ROIs, with the exception of the cerebellum and ventricles, 
regional atrophy was found in HdhQ150/Q150 mice (all p < 0.005).
From the MRI images, cortical thinning was found from 7- to 19-months old (F1,24 = 7.09, p < 0.05, Fig. 4), 
with a main effect of genotype (F1,24 = 13.30, p < 0.05) and no interaction between genotype and time, suggesting 
age affected both groups equally. Time interacted with cortical region; the most anterior cortical region (Bregma 
1.10mm) was significantly thinner over time (F1,24 = 21.58, p < 0.001), with a more modest effect of time at 
Bregma − 0.22 mm (F1,24 = 11.48, p < 0.01) and no difference at Bregma − 1.06 mm and 0.14 mm (both p > 0.05).
Ex vivo evidence. For higher-resolution ex vivo images acquired at 20 months old, the cerebellum and brain 
stem were not included in the TBV measure due to artefacts related to ex vivo preparation, thus TBV is not 
directly comparable to the in vivo measurements. There were no genotype differences in TBV in the ex vivo 
images (4.08%, F1,34 = 1.70, p > 0.05). As with the in vivo MRI results, after accounting for TBV there were no 
laterality effects (all p > 0.05), so the left and right ROIs were summed. There were no genotype differences in the 
absolute or normalised volume of the caudate-putamen, thalamus, globus pallidum, neocortex, hippocampus and 
the ventricles (all p > 0.05).
In accordance with the in vivo results, the absolute motor cortices measured from ex vivo MRI images were 
9.3% thinner in HdhQ150/Q150 mice (F1,33 = 12.57, p < 0.005, Fig. 4). The motor cortices in the histologically stained 
sections were 5.4% thinner in HdhQ150/Q150 mice compared to Hdh+/+ mice, but this did not meet statistical signif-
icance (F1,13 = 0.48, p > 0.05).
Tissue fixation produces lower estimates. Absolute volume was smaller in the ex vivo images at 
20-months compared to the in vivo images acquired at 19-months in the caudate-putamen (− 6.8%, t24 = − 
2.19, p < 0.05), thalamus (− 7.3%, t23 = − 4.21, p < 0.001) and hippocampus (− 9.02%, t24 = − 3.68, p < 0.01). 
There was no difference in the cortex (0.3%, t19 = − 1.0, p > 0.05), and an increase in globus pallidum volume 
(15%, t24 = 3.17, p < 0.01). The cerebral cortices were thinner when measured in stained tissue sections compared to 
ex vivo MRI (Wilks’ λ = 0.117, F1,12 = 90.37, p < 0.001).
HdhQ150 mice do not exhibit white matter microstructural abnormalities. Because of the sample 
size difference, white matter microstructure in the corpus callosum was examined separately at each age using 
t-tests. Mean values are shown in Fig. 4; at 7-months of age, prior to the onset of motor signs, there was no dif-
ference in tensor-based metrics, all p > 0.05. At 19-months of age when motor signs were evident, HdhQ150/Q150 
mice had reduced mean diffusivity (MD; t31 = 2.31, p = 0.028 uncorrected) and radial diffusivity (RD, t 31 = 2.43, 
p = 0.021 uncorrected) compared to Hdh+/+ mice, however these differences did not survive multiple comparison 
correction (FDR-adjusted p-value > 0.05). Importantly, when the same statistical analyses were performed on ten-
sor metrics corrected for CSF-related contamination15, the diffusivity differences observed between HDhQ150/Q150 
and Hdh+/+ were no longer significant (see Fig. 4 for comparison). For all DTI metrics and at both time points, 
there was a significant difference between uncorrected and corrected DTI metrics (all p < 0.001). This demon-
strates the importance of accounting for partial volume effects when studying white matter microstructure in the 
presence of atrophy.
The free water fraction did not differ between HdhQ150/Q150 and Hdh+/+ mice at 7 months (0.282  ± 0.011 
and 0.281 ± 0.010 respectively, t41 = − 0.077, p > 0.05), or 19 months (0.239 ± 0.014 and 0.253 ± 0.011 respec-
tively; t29 = 0.790, p > 0.05). Albeit with a reduce sample size, a repeated measures ANOVA assessed change over 
Region Volume
7 months 19 months
t df p t df p
TBV 3.32 42 <0.005 4.51 26 <0.001
Caudate-Putamen
Absolute 4.08 42 <0.001 3.65 26 <0.005
Normalised 1.56 42 >0.05 1.33 26 >0.05
Cortex
Absolute 3.06 42 <0.005 2.84 26 <0.01
Normalised 0.08 42 >0.05 − 0.5 26 >0.05
Cerebellum
Absolute 1.03 42 >0.05 0.3 26 >0.05
Normalised − 2.82 42 <0.01 − 3.29 26 <0.01
Thalamus
Absolute 3.48 42 <0.005 4.21 25 <0.001
Normalised 1.11 42 >0.05 0.46 25 >0.05
Globus Pallidum
Absolute 3.09 38 <0.005 2.43 26 <0.05
Normalised 1.37 38 >0.05 2.04 26 >0.05
Hippocampus
Absolute 3.6 42 <0.005 4.52 26 <0.001
Normalised 0.6 42 >0.05 0.4 26 >0.05
Lateral Ventricles
Absolute 2.71 38 <0.05 1.42 26 >0.05
Normalised 0.86 38 >0.05 − 1.19 26 >0.05
Table 1.  Outcome of t-tests between HdhQ150/Q150 and Hdh+/+ mice for absolute volume and regional 
volumes normalised by total brain volume (TBV). df: degrees of freedom.
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time. Fractional anisotropy (FA) was significantly reduced over time for both corrected and uncorrected data 
(F1,27 = 16.17 and 32.51 respectively, both p < 0.005), with no change in MD. There was a trend for a reduction 
in axial diffusivity (AD; λ 1) at 19-months compared to 7-months in the uncorrected data (F1,29 = 7.64, p = 0.01 
uncorrected, FDR-adjusted p > 0.05), whereas there was no effect of time in corrected AD values (F1,27 = 1.84, 
p > 0.05). For all DTI measures, there was no interaction between genotype and time (all p > 0.05). Similarly, 
from the electron microscopy images, axon density in the genu, body and splenium of the corpus callosum was 
not affected by genotype (Table 2, all p > 0.05). The percentage of decompacted axons was highly variable in both 
groups of mice, with no genotype differences (all p > 0.05).
Relationship between neuropathology and behaviour. To reduce the number of planned compari-
sons, a correlational analysis probed the association between structure and motor measures where deficits were 
found in the HdhQ150/Q150 mice. Free water fraction in the corpus callosum was negatively correlated with rearing 
frequency (normalised for body weight) on the Open Field task in Hdh+/+ mice (r = − 0.574, p < 0.05) and not in 
HdhQ150/Q150 mice, p > 0.05.
Similarly, locomotion over 24-hours correlated with cortical volume for Hdh+/+ mice (r = 0.642, p < 0.05) 
but not HdhQ150/Q150 mice, r = 0.304, p > 0.05. Rotarod performance in the HdhQ150/Q150 mice was associated with 
normalised thalamus volume (r = − 0.834, p < 0.05), however the direction of effect was counterintuitive, with 
superior rotarod performance associated with reduced thalamus volume.
Discussion
Neuropathology in the HdhQ150 mouse model of HD has previously been characterised using ex vivo tech-
niques2 beset by methodological issues associated with tissue fixatives and inherently limited to cross-sectional 
Figure 3. Top. Approximate Bregma positions for cortical thickness measures (red line = measurement). 
Bottom sections show representative stained sections for cortical thickness measures (blue = myelin). Graphs 
show cortical thickness measures from MRI images at different ages (left) and myelin-stained 40 μ m brain 
sections at 20 months old (right). WT: Hdh+/+ mice; HdhQ150: HdhQ150/Q150 mice.
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designs. In this first application of in vivo MRI to the HdhQ150 model, total brain volume (TBV) was reduced 
at 7-months, prior to the onset of motor signs, and at 19-months of age, when motor signs were present. After 
accounting for global atrophy, localised atrophy and cortical thinning were not evident and the cerebellum was 
Figure 4. Tractography of the corpus callosum. Top Left: arrows indicate ROI placement in the coronal plane 
overlaid on a map colour-coded for the principal diffusion vector. Top middle (coronal) and top right (axial) 
panes shows tracts overlaid on a single subject FA map. Line graphs show DTI metrics before and after partial 
volume correction. Uncorr = uncorrected data, ***p < 0.005. N = 22/22 at 7-months; N = 19/14 at 19-months, 
for Hdh+/+/HdhQ150/Q150 respectively.
Number of fibers measured ± S.D. Mean axon density (axon/μm2) ± S.D.
Genu Body Splenium Genu Body Splenium
Total
HdhQ150/Q150 1224.4 ± 201.0 1408 ± 443.2 1213.4 ± 414.9 0.75 ± 0.11 0.86 ± 0.26 0.74 ± 0.24
Hdh+/+ 1246.0 ± 389.0 932.6 ± 490.1 1199.4 ± 547.0 0.67 ± 0.29 0.57 ± 0.28 0.73 ± 0.32
% Decompacted (decompacted axons/total axons)
Myelin decompaction
HdhQ150/Q150 70.4 ± 35.5 146.6 ± 93.3 126.2 ± 108.7 5.96 ± 2.8 11.22 ± 6.8 12.99 ± 12.5
Hdh+/+ 60.0 ± 49.3 90.4 ± 66.7 140.6 ± 140.7 7.13 ± 6.3 12.89 ± 9.7 10.62 ± 9.7
Table 2.  Axon fibre density and myelin structure in the corpus callosum of the HdhQ150/Q150 and Hdh+/+ 
mouse obtained from electron microscopy images.
www.nature.com/scientificreports/
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relatively spared at both time points. White matter microstructural abnormalities were not detected in the corpus 
callosum at any age, in contrast to patient work and ex vivo analyses in alternative HD models7,8.
The MRI analyses provides additional, unique information to histology, examining whole structures rather 
than selective slices through a structure. The results are in accordance with histological work in the same mouse 
model14, and further show that volume loss is global and not specific to the striatum from 7 months of age. The 
selective sparing of the cerebellum fits with an anterior-posterior pattern of pathology2 although atrophy in spe-
cific cerebellar subregions has been observed in symptomatic HD patients16. The globalised atrophy observed 
agrees with work in pre-symptomatic gene carriers, where a smaller intracranial brain volume was found17.
HdhQ150/Q150 mice had prominent motor deficits at 19-months. A novel finding was a relationship between 
rearing frequency and free water fraction along the corpus callosum, reconstructed from in vivo diffusion MRI 
data, in Hdh+/+ mice but not HdhQ150/Q150 mice, suggesting a disturbed relationship between white matter struc-
ture and motor function in HD. MRI provides a unique opportunity to assess free water in the intact brain, and 
previous work has shown altered free water in HD5, schizophrenia18, brain injury19 and Parkinson’s disease20. 
Counterintuitively, larger thalami were associated with a shorter latency to fall on the rotarod specifically in 
HdhQ150/Q150 mice. The direction of effect highlights the difficulty in interpreting volume measures which may be 
sensitive to numerous pathological processes aside from cell loss including cellular swelling or other inflamma-
tory responses. This demonstrates that whereas MRI is highly sensitive to neuropathology, ex vivo histological 
measures provide biological specificity not currently possible with in vivo MRI.
No white matter microstructural changes were found in the HdhQ150/Q150 mice despite corpus callosum 
abnormalities reported in pre-symptomatic and symptomatic HD participants5,21. White matter anatomy differs 
between species22 and it is unclear if functional subdivisions exist in the mouse corpus callosum which may 
dilute effects when analysed as a homogenous structure. The lack of difference in axon density and myelin struc-
ture from the microscopy analysis corroborates the MRI result and suggests that the null finding is not due to 
insufficient sensitivity. However, the statistical tests conducted at the second in vivo time point showed a trend 
towards changes in the diffusivity metrics (MD and RD) in the corpus callosum. MD and RD were both reduced 
in HdhQ150/Q150 mice although this difference was not significant after adjusting the p-value for multiple compari-
sons and CSF-related partial volume contamination. This highlights the importance of correcting for partial vol-
ume for reliable white matter microstructure characterisation. The results suggest that in comparison to marked 
grey matter atrophy early in the disease course, white matter abnormalities may be more subtle and occur later, 
requiring larger sample sizes to detect more modest effects. The microscopy analyses found no difference in axon 
density, count or myelin decompaction, yet further studies with higher-resolution images are necessary to exam-
ine myelin sheath thickness.
The lack of localised atrophy after accounting for global volume contrasts with patient studies23. A change in 
volume over 12-months in the mouse does not readily translate to a period of time in humans, and conceivably an 
earlier time point in the mouse was necessary to capture localised changes. Interpreting reduced brain volume in 
terms of biophysical changes and in relation to previous immunohistochemistry findings is not straightforward 
due to differences in scale. Whereas the number of intra-nuclear inclusions increased with time in HdhQ150/Q150 
mice14, neuronal count was reduced from 6 months of age with no continued decline14. This absence of a pro-
gressive phenotype beyond 6 months combined with diffuse mutant Htt staining from an early age supports the 
pattern of results we observed.
Whole brain atrophy was found to be stable across time which may suggest that either widespread atrophy 
occurs early and is not progressive, or that the mutant gene affects development. A smaller intracranial volume 
has been reported in pre-symptomatic HD participants17 however progressive whole brain volume loss is evident 
in pre-symptomatic and symptomatic HD participants24. Compared to Hdh+/+ mice, HdhQ150/Q150 mice did not 
reach a normal mature adult weight, which, in combination with global brain atrophy at 7 months, may indicate 
abnormal developmental processes. The concept of mutant HTT affecting developmental processes is not new25 
with HTT regulating cortical neurogenesis26. Thus, further study should be directed toward exploring the contri-
bution of neurodevelopmental processes in HD.
Despite no difference in lifespan, HdhQ150/Q150 mice were less tolerant of anaesthesia required for the MRI 
acquisition at 19-months old, with a significantly higher mortality rate. This could be explained by numerous 
factors, including a change in oxygen consumption rate affecting survival for hypoxemia, a difference in meta-
bolic rate, thermoregulatory efficiency, or a difference in hepatic glycogen reserves in the aged HdhQ150/Q150 mice. 
As mutant Htt is expressed throughout the entire body, it is likely that deficits in hepatic, renal and/or cardiac 
systems affected the response to anaesthesia; cardiac abnormalities have recently been shown in HdhQ150/Q150 
mice27, and hepatic dysfunction is an area of recent research attention in HD28. This highlights that the suitability 
of an anaesthetic procedure is dependent on mouse strain, age and weight29 which is problematic in longitudinal 
studies where age and weight are not fixed.
Ex vivo volumetric measurements were significantly lower compared to in vivo measures, with some regions 
more severely affected, and were less sensitive to genotype effects. The chemical fixation and staining process 
resulted in a reduced sample size due to the removal of poor quality samples from the analysis, which may explain 
the different statistical findings. This suggests that a sole reliance on ex vivo techniques may underestimate or dis-
tort the spatial and temporal pattern of neuropathology. Whereas the MRI measurements came from both hemi-
spheres, the immunohistochemistry and electron microscopy were conducted on one hemisphere each which can 
increase tissue damage during processing.
Concluding Comment
Here we demonstrate that longitudinal in vivo MRI has the sensitivity to detect disease-related macrostructural 
changes in a knock-in mouse model of HD. There was no evidence for white matter microstructural abnormal-
ities at any age, validated with electron microscopy analyses, which contrasts with the patient literature. This 
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may suggest that the precision of genetic models to recapitulate neuropathology varies with tissue type. As with 
previous work10, the link between neuropathology and behavioural deficits was not clear, with evidence for a 
disturbed structure-function relationship in the HD mice for motor coordination. Investigations into other symp-
tom modalities are required to ascertain the extent of structure-function disturbances.
Methods
Ethics statement. All procedures followed protocols in accordance with the United Kingdom Animals 
(Scientific Procedures) Act of 1986, approved by Cardiff University Ethical Review Process Committee, carried 
out under Home Office License 30/3036.
Animals. Homozygous HdhQ150/Q150 mice were bred in-house using a heterozygous mutant × heterozygous 
mutant breeding regime on the 129/Ola × C57BL6/J background12. Genotype was confirmed by tail tipping 
(Laragen Inc., Los Angeles, USA). Mean CAG repeat length on allele 1 was 147 ± 7 SD and 158 ± 5 on allele 2. In 
total, 25 HdhQ150/Q150 male mice and 25 age-matched Hdh+/+ male mice were used.
Mice were housed in mixed genotype groups of between 1 and 3 mice with moderate enrichment, and subject 
to a 12-hour light: dark cycle with controlled room temperature (21 ± 3 °C) and relative humidity (60 ± 3%). 
7-months of age was selected to represent the pre-symptomatic disease stage, with the absence of motor signs; and 
19 months of age was selected as the symptomatic time point. Fighting between cagemates due to long separation 
times during MRI scanning occurred at 7 months, thus all mice were individually housed thereafter. Mice were 
weighed monthly as progressive weight loss is a sign of disease progression and is a core feature of these mouse 
models30.
Magnetic Resonance Imaging. The experimental design is shown in Supplementary Figure 3. Data were 
acquired on a 9.4 Tesla small bore (20 cm) Bruker Biospin system, equipped with BGA12-S (12 cm inner bore 
size, integrated shims) gradients. A transmit 1H 500 Watt echo-planar imaging (EPI) volume coil was used with a 
phased array 4-channel surface coil and Paravision software (version 5.1, Bruker Biospin).
In vivo longitudinal MRI. To improve animal health and recovery, 500 μ l of glucose saline was administered 
via sub-cutaneous injection immediately prior to, and immediately after the MRI session. Animals were anaes-
thetised with isofluorane (5% for induction, 1.8–2.2% for maintenance, mixed with 100% oxygen) delivered at 
~1 litre/minute. At 19 months, the long scan time was poorly tolerated, thus the scan was split into two sessions 
one week apart.
A 3D Turbo Rapid Acquisition with Refocused Echoes (RARE) T2-weighted scan was used both in vivo and 
ex vivo. The in vivo in-plane resolution was 120 × 120 μ m with a field of view (FOV) of 1.54 × 1.54 cm, matrix of 
128 × 128 × 64, TR/TE = 1750/17.5 ms, bandwidth 50000 Hz, RARE factor of 4, 1 average, and an acquisition 
time of approximately 1 hour 8 minutes. For the ex vivo sequence, the image resolution was 60 μ m3 with the fol-
lowing parameters: FOV 1.54 cm × 1.54 cm × 1.02 cm, matrix = 256 × 256 × 168, TR/TE = 1750/17.5 ms, band-
width 50000 Hz, RARE factor of 4, 3 averages, with an acquisition time of 11 hours.
At both in vivo time points, a multi-shot DTI echo-planar imaging (EPI) MRI sequence was acquired with 27 
contiguous axial slices of 320 μ m in thickness. Navigator echoes minimised distortion artefacts and 2 averages 
increased the SNR. The in-plane resolution was 213 μ m × 213 μ m at a FOV of 2.24 cm × 2.24 cm and an acqui-
sition matrix of 96 × 96. A partial Fourier acquisition (acceleration factor = 1.35, 23 overscan lines) was used to 
reduce the acquisition time. 4 dummy scans were used to achieve magnetisation equilibrium. Respiratory-gating 
was used to reduce motion artefacts. Data were acquired with a b-value of 1000 s/mm2 applied over 30 
isotropically-distributed diffusion-weighted directions (Jones 3031) with 3 b0 images, TR/TE = 8500/18.70 ms, 
δ /Δ = 4/9 ms. The average acquisition time was 1 hour.
Deterministic Tractography. Post-processing of diffusion MRI images was conducted using ExploreDTI 
(version 4.8.3) software32 as previously described in Steventon et al.5. Briefly, images were corrected for distortions 
due to motion, eddy currents and field inhomogeneity33 and any rotations applied were also applied to the encod-
ing vector34 and the signal intensity was modulated by the Jacobian determinant of the transformation35. Images 
were corrected for contamination due to atrophy-related free water15.
Whole-brain deterministic tracking was conducted using a home-written software plugin to perform damped 
Richardson-Lucy deconvolution36 (DRL), a spherical deconvolution approach capable of resolving crossing fibres. 
The tracking algorithm estimated the fibre orientation distribution function (fODF) at each seed point and prop-
agated in 0.05 mm steps along this direction, with an angle threshold of 40°. Three-dimensional corpus callosum 
reconstructions were extracted from the whole-brain tractograms using multiple ROIs drawn manually in native 
space by a single blinded operator (JJS). An initial ROI was drawn on the mid-sagittal plane; the analysis was 
restricted to corpus callosal fibres using two additional ‘AND’ gate ROIs (which segment fibres that traverse 
both ROIs) drawn in the sagittal plane in line with the medial cingulum in both hemispheres (Fig. 4). Mean 
tensor-based metrics (FA, MD, AD, RD) and free water fraction were obtained.
Behaviour Assessment. At 20 months of age, mice were assessed for motor deficits in open field, rotarod 
and spontaneous locomotor activity.
The Open field test. The open field test was conducted using Ethovision Pro version 2.3.19 software (Noldus 
Information Technology, Netherlands) to investigate anxiety-related and exploratory behaviour. Total locomo-
tion, average time spent moving, velocity and rearing frequency was measured in a square test arena (81 × 81 cm) 
containing 9 equally-spaced quadrants using a camcorder (Sanyo CCD camera) over a 20 minute period.
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Rotarod. The rotarod test37 was used to assess motor coordination, balance and endurance38,39. Mice were 
trained and tested on the accelerating rotarod (3.1 cm diameter) apparatus (Ugo Basile Research Apparatus, 
Varese, Italy). Training consisted of two 5-minute trials on 2 consecutive days; the training protocol involved 
15 seconds of fixed speed, followed by a period of accelerating speed, with each successive period increasing in 
duration. During training, when mice fell off the rod they were placed back on until the full time had elapsed. 
There were 2 trials on the testing day (the day after the training day), with the speed of revolutions increasing 
from 4 to 44 r.p.m over a maximum period of 300 s. The two trials were 15 minutes apart. The latency to fall was 
recorded for each trial.
Locomotor activity. To measure spontaneous locomotor activity over the diurnal cycle, mice were transferred to 
clear Perspex activity chambers (40 cm × 24 cm × 18 cm) containing food and water for 27 hours. The chambers 
were fitted with 8 infra-red sensors and the total number of beam breaks made in 5-minute intervals was recorded 
on MED Associate hardware and MED-PC® software (Vermont, USA). Lights were on a 12-hour timer to avoid 
experimenter interference (light phase [18:00–05:59]; dark phase [06:00–17:59]). Transfer/habituation activity 
was measured during the first 2 hours; circadian-related activity was assessed over 24 hours (from hour 3 to 27) 
after allowing for acclimatisation.
Perfusion. Mice were terminally anaesthetised via intraperitoneal injection of Euthatal (0.1 ml), and then 
perfused with phosphate buffered saline (PBS, 60 ml) followed by 4% paraformaldehyde (PFA, 150 ml) in PBS 
(pH 7.3) at a flow rate of 30 ml/min. The skulls underwent post-fixation in 4% PFA in PBS overnight and were 
transferred to a 25% sucrose solution.
Histology. After ex vivo imaging, brains were removed from the skulls and transferred to a 25% sucrose solu-
tion until they sank. Brains were bisected at the midline.
Immunohistochemistry. From the left hemisphere, coronal sections of 40 μ m were cut on a freezing sledge 
microtome and stored at − 20 °C in tissue cryoprotective solution. All sections were stained at the same time with 
a 1 in 6 series; sections were first placed in tris buffered saline (pH = 7.4) and washed twice. Solochrome cyanine 
was used to identify myelin and thus differentiate grey matter from white matter. The tissue was hydrated by serial 
washes in 100%, 95% and 70% ethanol and distilled water for 5 minutes each and then immersed for 35 minutes 
in solochrome cyanine solution. Sections were thoroughly washed and differentiation was carried out in 10% Iron 
Alum for 2–3 minutes, halted by thorough washing. Sections were dehydrated by serial washes in 70%, 95% and 
100% ethanol for 2 minutes each, cleared in xylene, and cover-slipped with DPX mounting medium (RA Lamb, 
Eastbourne, UK).
Cortical measurements. Cortical thickness measurements may provide unique information not captured by 
cortical volume alone40,41. Changes in cortical thickness may reflect a change in the size, density and arrangement 
of neurons, dendritic arborisation, myelination change, and neuroglia, therefore cortical thickness can provide 
unique and important information about the effects of HD not captured by cortical volume alone. Previous work 
in HD has shown that with increased disease progression, changes were more evident in cortical thickness meas-
ures compared to cortical.
Cortical thickness was measured on approximately the same coronal sections for both the MRI images and 
the prepared brain sections (Fig. 3). Analysis was conducted using Analyze software (version 10.0) for the MRI 
images and using a Leica microscope at a 5x objective with background correction for uneven illumination for 
the mounted brain sections. Cortical thickness was measured in primary motor cortex (M1) at approximately 
Bregma 1.10mm, 0.14 mm, − 0.22mm and − 1.06 mm.
Electron microscopy. 200μ m thick sections were cut from the right hemisphere on a Leica vibrating-blade 
microtome (VT1000 S) and stored at 4 °C in 0.1M PBS + azide. The tissue was post-fixed in 2% osmium tetrox-
ide (90 minutes), then dehydrated in isopropanol (50%, 70%, 90%, 2 × 100%, 10 minutes each). Following this, 
the tissue was infiltrated with embedding resin (50% in isopropyl alcohol for 30 minutes, pure resin 4 × 1 hour, 
TAAB Laboratories) and then cured for 16 hours at 60 °C. Ultra-thin sections (80 nm) were cut and collected on 
300-mesh copper grids, and post-section stained with 4% uranyl acetate and then with Reynolds’ lead citrate. 
Sections were examined using a Philips CM12 transmission electron microscope (TEM) operated at 80 kV (FEI 
Ltd, Cambridge) at 4,400x magnification. From each section, 5 images were acquired using a MegaView III digital 
TEM camera and iTEM software (Soft Imaging System GmbH, Münster, Germany), resulting in a total of 75 
images (10 mice [5 HdhQ150/Q150, 5 Hdh+/+] × 3 regions × 5 images per region), image area = 327.5 μ m2. Image 
analysis was conducted using ImageJ; all axons in all images were counted and the axon density calculated (no. of 
axons per μ m2 tissue) with a minimum of 100 axons counted per region, along with the total number of decom-
pacted axons, defined as those with split myelin and/or with distinct, multiple lanullae layers42. Sample images 
and examples of myelin decompaction are shown in Supplementary Figure 4.
Data Quality Assessments. After visual inspection of the atlas-based segmentation, the globus pallidum 
and ventricles were removed from the analysis for 2 Hdh+/+ mice and 2 HdhQ150/Q150 mice and the thalamus was 
removed from the analysis for 1 Hdh+/+ mouse at 7 months due to imperfect segmentation. For ex vivo images, 
the cortex was excluded from the analyses for 5 Hdh+/+ mice, due to imperfect segmentation and/or damage to 
the cortex in sample preparation.
Statistical Analysis. All statistical analysis was performed using SPSS (version 20, IBM, Portsmouth, UK). 
Extreme outlier values, defined as those over 3 standard deviations from the mean, were excluded case-wise. Due 
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to outlier removal, animal loss and occasional missing values, the number of animals included for each analysis 
at different time points varied. For post-hoc analyses, data was corrected for multiple comparisons using the false 
discovery rate (FDR) at 5%.
It was not possible to assess natural attrition across the lifespan as some mice did not recover from anaesthesia. 
Instead, a chi-square test examined survival during the first 7 months, and from 7–19 months, separately from 
survival during the two scan sessions.
Weight was included as a covariate for motor function analyses when Pearson’s correlation coefficient between 
weight and motor performance was greater than 0.3. The assumption of homogeneity of regression slopes was 
tested; when weight significantly interacted with genotype and the direction of the relationship was the same for 
HdhQ150/Q150 and Hdh+/+ mice, weight was added as a covariate and both the main effects of genotype and the 
corrected model, encompassing the contribution of weight, are reported.
Atlas-based segmentation of T2-weighted images. T2-weighted images were analysed using an auto-
mated multi-atlas based parcellation pipeline43. Briefly, the brain was digitally extracted to exclude non-brain 
tissue by creating a mask from multiple atlas images44. The MRM atlas45 was selected based on superior parcella-
tion accuracy. The native subject image was globally registered to all atlas images using a block-matching-based 
symmetric affine registration46 and the resulting transformation matrices were inverted and used to propagate 
the atlas masks to the native image. The resulted brain mask candidates were fused47 and this final mask was 
dilated to include the contrast between brain tissue and CSF. The non-parametric non-uniform intensity nor-
malization technique (N3) was used (see Supplementary Figure 2) and the affinely-aligned atlas images were 
then non-linearly registered to each mouse image48, with the resulting deformation fields used to propagate the 
labels from atlas space to native space. These labels were fused using the STEPS algorithm49. From the labelled 
images, the caudate putamen, thalamus, globus pallidus, hippocampus, neocortex, cerebellum and ventricles were 
extracted (Supplementary Figure 2) and the volume calculated. The total in vivo brain volume was the summed 
volume across all ROIs.
References
1. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. The 
Huntington’s Disease Collaborative Research Group. Cell 72, 971–983 (1993).
2. Brooks, S. P., Jones, L. & Dunnett, S. B. Comparative analysis of pathology and behavioural phenotypes in mouse models of 
Huntington’s disease. Brain Res. Bull. 88, 81–93 (2012).
3. Dumas, E. M. et al. Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington’s disease. Hum. 
Brain Mapp. 33, 203–212 (2012).
4. Reading, S. A. J. et al. Regional white matter change in pre-symptomatic Huntington’s disease: a diffusion tensor imaging study. 
Psychiatry Res. 140, 55–62 (2005).
5. Steventon, J. J., Trueman, R. C., Rosser, A. E. & Jones, D. K. Robust MR-based approaches to quantifying white matter structure and 
structure/function alterations in Huntington’s disease. J. Neurosci. Methods, doi: 10.1016/j.jneumeth.2015.08.027 (2015).
6. Rosas, H. D. et al. Altered white matter microstructure in the corpus callosum in Huntington’s disease: implications for cortical 
‘disconnection’. Neuroimage 49, 2995–3004 (2010).
7. Marangoni, M. et al. Age-related axonal swellings precede other neuropathological hallmarks in a knock-in mouse model of 
Huntington’s disease. Neurobiol. Aging 35, 2382–2393 (2014).
8. Gatto, R. G. et al. Analysis of YFP(J16)-R6/2 reporter mice and postmortem brains reveals early pathology and increased 
vulnerability of callosal axons in Huntington’s disease. Hum. Mol. Genet. 24, 5285–5298 (2015).
9. Alexander, A., Hasan, K. M., Lazar, M., Tsuruda, J. S. & Parker, D. L. Analysis of partial volume effects in diffusion-tensor MRI. 
Magn Reson Med 45, 770–780 (2001).
10. Rattray, I. et al. Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in 
the R6/2 mouse model of HD. PLoS One 8, e60012 (2013).
11. Steventon, J. J. et al. In Vivo MRI Evidence that Neuropathology is Attenuated by Cognitive Enrichment in the Yac128 Huntington’s 
Disease Mouse Model. J. Huntingtons. Dis. 4, 149–160 (2015).
12. Lin, C. H. et al. Neurological abnormalities in a knock-in mouse model of Huntington’s disease. Hum. Mol. Genet. 10, 137–144 
(2001).
13. Heng, M. Y., Tallaksen-Greene, S. J., Detloff, P. J. & Albin, R. L. Longitudinal evaluation of the Hdh(CAG)150 knock-in murine 
model of Huntington’s disease. J. Neurosci. 27, 8989–8998 (2007).
14. Bayram-Weston, Z., Torres, E. M., Jones, L., Dunnett, S. B. & Brooks, S. P. Light and electron microscopic characterization of the 
evolution of cellular pathology in the Hdh(CAG)150 Huntington’s disease knock-in mouse. Brain Res. Bull. 88, 189–198 (2012).
15. Pasternak, O., Sochen, N., Gur, Y., Intrator, N. & Assaf, Y. Free water elimination and mapping from diffusion MRI. Magn. Reson. 
Med. 62, 717–730 (2009).
16. Wolf, R. C. et al. Abnormal cerebellar volume and corticocerebellar dysfunction in early manifest Huntington’s disease. J. Neurol. 
262, 859–869 (2015).
17. Nopoulos, P. C. et al. Cerebral cortex structure in prodromal Huntington disease. Neurobiol. Dis. 40, 544–554 (2010).
18. Pasternak, O. et al. Excessive Extracellular Volume Reveals a Neurodegenerative Pattern in Schizophrenia Onset. J. Neurosci. 32, 
17365–17372 (2012).
19. Pasternak, O. et al. Hockey Concussion Education Project, Part 2. Microstructural white matter alterations in acutely concussed ice 
hockey players: a longitudinal free-water MRI study. J. Neurosurg. 120, 873–881 (2014).
20. Ofori, E. et al. Increased free water in the substantia nigra of Parkinson’s disease: a single-site and multi-site study. Neurobiol. Aging 
36, 1097–1104 (2015).
21. Di Paola, M. et al. Multimodal MRI analysis of the corpus callosum reveals white matter differences in presymptomatic and early 
Huntington’s disease. Cereb. Cortex 22, 2858–2866 (2012).
22. Treuting, P. M. & Dintzis, S. M. Comparative Anatomy and Histology: A Mouse and Human Atlas. (Elsevier., 2012).
23. Tabrizi, S. J. et al. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington’s disease in the 
TRACK-HD study: analysis of 36-month observational data. Lancet. Neurol. 12, 637–649 (2013).
24. Tabrizi, S. J. et al. Biological and clinical changes in premanifest and early stage Huntington’s disease in the TRACK-HD study: the 
12-month longitudinal analysis. Lancet. Neurol. 10, 31–42 (2011).
25. Mehler, M. F. & Gokhan, S. Mechanisms underlying neural cell death in neurodegenerative diseases: alterations of a 
developmentally-mediated cellular rheostat. Trends Neurosci 23, 599–605 (2000).
26. Godin, J. D. et al. Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis. Neuron 67, 392–406 (2010).
www.nature.com/scientificreports/
1 2Scientific RepoRts | 6:32423 | DOI: 10.1038/srep32423
27. Mielcarek, M. et al. Dysfunction of the CNS-heart axis in mouse models of Huntington’s disease. PLoS Genet. 10, e1004550 (2014).
28. Hoffmann, R. et al. Progressive hepatic mitochondrial dysfunction in premanifest Huntington’s disease. Mov Disord 29, 831–834 
(2014).
29. Gargiulo, S. et al. Mice anesthesia, analgesia, and care, Part II: anesthetic considerations in preclinical imaging studies. ILAR J 53, 
E70–E81 (2012).
30. Brooks, S., Higgs, G., Jones, L. & Dunnett, S. B. Longitudinal analysis of the behavioural phenotype in Hdh(CAG)150 Huntington’s 
disease knock-in mice. Brain Res. Bull. 88, 182–188 (2012).
31. Jones, D. K., Horsfield, M. A. & Simmons, A. Optimal strategies for measuring diffusion in anisotropic systems by magnetic 
resonance imaging. Magn. Reson. Med. 42, 515–525 (1999).
32. Leemans, A., Jeurissen, B. & Sijbers, J. ExploreDTI: a graphical toolbox for processing, analyzing, and visualizing diffusion MR data. 
Proc Intl Soc Mag Reson. (2009).
33. Anand, S. et al. Immune response studies with Wuchereria bancrofti vespid allergen homologue (WbVAH) in human lymphatic 
filariasis. Parasitol. Res. 101, 981–988 (2007).
34. Leemans, A. & Jones, D. K. The B-matrix must be rotated when correcting for subject motion in DTI data. Magn. Reson. Med. 61, 
1336–1349 (2009).
35. Jones, D. K. & Cercignani, M. Twenty-five pitfalls in the analysis of diffusion MRI data. NMR Biomed. 23, 803–820 (2010).
36. Dell’Acqua, F. et al. A modified damped Richardson-Lucy algorithm to reduce isotropic background effects in spherical 
deconvolution. Neuroimage 49, 1446–1458 (2010).
37. Jones, B. J. & Roberts, D. J. The quantiative measurement of motor inco-ordination in naive mice using an acelerating rotarod. 
J. Pharm. Pharmacol. 20, 302–304 (1968).
38. Alvarez-Fischer, D. et al. Characterization of the striatal 6-OHDA model of Parkinson’s disease in wild type and alpha-synuclein-
deleted mice. Exp Neurol 210, 182–193 (2008).
39. Schallert, T., Fleming, S. M., Leasure, J. L., Tillerson, J. L. & Bland, S. T. CNS plasticity and assessment of forelimb sensorimotor 
outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39, 777–787 
(2000).
40. Qiu, L. et al. Regional increases of cortical thickness in untreated, first-episode major depressive disorder. Transl. Psychiatry 4, e378 
(2014).
41. Winkler, A. M. et al. Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics 
studies. Neuroimage 53, 1135–1146 (2010).
42. Payne, S. C., Bartlett, C. A., Harvey, A. R., Dunlop, S. A. & Fitzgerald, M. Chronic swelling and abnormal myelination during 
secondary degeneration after partial injury to a central nervous system tract. J. Neurotrauma 28, 1077–1088 (2011).
43. Ma, D. et al. Automatic structural parcellation of mouse brain MRI using multi-atlas label fusion. PLoS One 9, e86576 (2014).
44. Leung, K. et al. Automated brain extraction using multi-atlas propagation and segmentation (MAPS). 8TH IEEE Int. Symp. Biomed. 
Imaging: From nano to macro. 2053–2056 (2011).
45. Ma, Y. et al. A three-dimensional digital atlas database of the adult C57BL/6J mouse brain by magnetic resonance microscopy. 
Neuroscience 135, 1203–1215 (2005).
46. Ourselin, S., Roche, A., Prima, S. & Ayache, N. Block matching: A general framework to improve robustness of rigid registration of 
medical images. Proc MICCAI Int Conf Med Image Comput Comput Assist Interv. 1935, 557–566 (2000).
47. Warfield, S. K., Zou, K. H. & Wells, W. M. Simultaneous truth and performance level estimation (STAPLE): an algorithm for the 
validation of image segmentation. IEEE Trans. Med. Imaging 23, 903–921 (2004).
48. Modat, M. et al. Fast free-form deformation using graphics processing units. Comput Methods Programs Biomed 98, 278–284 (2010).
49. Jorge Cardoso, M. et al. STEPS: Similarity and Truth Estimation for Propagated Segmentations and its application to hippocampal 
segmentation and brain parcelation. Med Image Anal 17, 671–684 (2013).
Acknowledgements
We wish to thank Chris Von Ruhland at the Electron Microscopy Unit (Cardiff University) for preparation and 
processing of the EM sections and the Wellcome Trust for funding this work. D.K.J. is supported by a Wellcome 
Trust New Investigator Award.
Author Contributions
J.J.S. wrote the manuscript and conducted the data collection and analysis. E.Y. conducted the electron 
microscopy analysis, Z.B.W. advised on the ex vivo analyses, M.D. developed and implemented the automated 
segmentation pipeline, under the supervision of M.M., J.C., S.O. and M.L. A.S. assisted with data collection and 
sample preparation, A.E.R., R.C.T. and D.K.J. jointly supervised the work. All authors reviewed the manuscript.
Additional Information
Supplementary information accompanies this paper at http://www.nature.com/srep
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Steventon, J. J. et al. Longitudinal in vivo MRI in a Huntington’s disease mouse model: 
Global atrophy in the absence of white matter microstructural damage. Sci. Rep. 6, 32423; doi: 10.1038/
srep32423 (2016).
This work is licensed under a Creative Commons Attribution 4.0 International License. The images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, 
users will need to obtain permission from the license holder to reproduce the material. To view a copy of this 
license, visit http://creativecommons.org/licenses/by/4.0/
 
© The Author(s) 2016
